⌘K

Home/Filings/4/0001209191-21-004095

4//SEC Filing

MORNEAU MICHAEL 4

Accession 0001209191-21-004095

CIK 0001607678other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 6:21 PM ET

Size

4.8 KB

Accession

0001209191-21-004095

Insider Transaction Report

Form 4

Period: 2021-01-19

Viking Therapeutics, Inc.VKTX

MORNEAU MICHAEL

Chief Financial Officer

Transactions

Tax Payment
Common Stock, par value $0.00001 per share
2021-01-19$6.68/sh−1,685$11,256→ 116,062 total

Footnotes (1)

[F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viking Therapeutics, Inc.

CIK 0001607678

Entity typeother

Related Parties

1

filerCIK 0001517780

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 6:21 PM ET
Size: 4.8 KB

View on SEC.gov